Latest


Sun Pharma completes acquisition of US InSite Vision

  •   Tue, Nov 03 2015 11:48:47 AM

Chennai, Nov 3 (IANS): Sun Pharmaceutical Industries Ltd on Tuesday said it has successfully completed the acquisition of US based ophthalmic drug maker InSite Vision Inc.

In a statement, Sun Pharma said the acquisition was completed by means of a short-form merger under Delaware law.

Post the short-form merger, Insite has become an indirect wholly owned subsidiary of Sun Pharma, the statement added.
  

Top Stories


Leave a Comment

Title: Sun Pharma completes acquisition of US InSite Vision



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

You might also like